Trending

#LKB1

Latest posts tagged with #LKB1 on Bluesky

Latest Top
Trending

Posts tagged #LKB1

JCI - Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of LKB1 and SYVN1

❄️☕👩🏻‍💻

Proanthocyanidins enhance antitumor immunity by promoting ubiquitin-proteasomal PD-L1 degradation via stabilization of #LKB1 and SYVN1 www.jci.org/articles/vie...

2 1 0 0

www.sciencedirect.com/science/arti...

Authors combined targeted NGS with STAS and LVI scoring and organ-specific metastasis profiling within a single well-defined NSCLC cohort. This design allows them to directly link #STK11 mutation subtypes with distinct clinical and metastatic phenotypes. #LKB1

1 0 1 0
Post image

This review highlights the role of #LKB1 in #Tumorigenesis and its therapeutic relevance in #Oncology, offering new insights into targeted #CancerTherapy. @westernu.bsky.social #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

1 1 0 0

Clinical data from lung adenocarcinoma patients with KRASG12C and #STK11 #LKB1 mutations were analyzed, looking for correlation between high squamous gene signature at baseline and response to adagrasib. Analysis reveals patients with a high squamous gene signature had poorer responses to treatment.

1 0 1 0
Post image

#LKB1 mutation (shown by green fluorescent protein) in lung cancer #metastasis. Beautiful image. Red = Actin. Cell nuclei in blue. 😍

Credit: National Cancer Institute / Winship Cancer Institute of Emory University / Science Photo Library @winshipatemory.bsky.social

#STK11

4 0 0 0
Preview
Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer Up to one third of all breast cancers are classified as the aggressive HER2-positive subtype, which is associated with a higher risk of recurrence compared to HER2-negative breast cancers. The HER2 hy...

Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer

If LKB1 is removed (or "knocked out"), the activation of #AMPK by PKA is significantly reduced. However, even without #LKB1 ( #STK11 ), there is still some activation of AMPK.

4 1 1 0

The research found that high expression levels of certain genes associated with #LKB1 signaling, such as #AMPK, #LYK5, and #PAK1, correlated with improved survival rates across all breast cancer types studied.

2 0 0 0

Different breast cancer subtypes respond differently to #LKB1 signaling. For instance, while some genes like #PAK1 and #SIK2 are linked to improved survival in Triple-Negative Breast Cancer (TNBC) before chemotherapy, their impact changes after treatment.

0 0 1 0
Preview
Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment | Oncotarget https://doi.org/10.18632/oncotarget.27929 Khoa Nguyen, Andrew Rivera, Madlin Alzoubi, Henri Wathieu, Shengli Dong, Hassan Yousefi, Margarite Matossian, Suresh Alahari, David Drewry, Matthew Burow,...

Authors evaluated #LKB1 signaling pathway gene expression associations with patient survival in overall breast cancer, specific subtypes, as well as pre- and post-chemotherapy.

1 0 1 0
Preview
Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC Standard first-line therapy for patients with metastatic non-small cell lung cancer (mNSCLC) without identified actionable mutations consists of regimens comprising immune checkpoint inhibitors (ICIs)...

pmc.ncbi.nlm.nih.gov/articles/PMC...

#stk11 #lkb1

1 0 0 0

Understanding the metabolic consequences of #LKB1 inactivation could provide critical insights for developing targeted therapies in this #cancer type

1 0 0 0
Preview
Frontiers | Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies Currently, immune checkpoint inhibitors (ICIs) are widely considered the standard initial treatment for advanced non-small cell lung cancer (NSCLC) when ther...

Given that current immune checkpoint inhibitors (ICIs) are less effective in patients with #LKB1 and #KEAP1 mutations, there is a pressing need for new treatment approaches. This paper suggests that combining ICIs with therapies targeting metabolic pathways could improve outcomes for these patients.

1 0 0 0
Preview
LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma Despite the confirmed role of LKB1 in suppressing lung cancer progression, its precise effect on cellular senescence is unknown. The aim of this resea…

www.sciencedirect.com/science/arti...

Targeting telomerase could be a viable strategy in cancer treatment. This could lead to the development of new drugs that specifically inhibit telomerase in lung cancer cells 🤔 #LKB1

1 0 0 0
Preview
Insights into targeting LKB1 in tumorigenesis Genetic alterations to serine-threonine kinase 11 (STK11) have been implicated in Peutz-Jeghers syndrome and tumorigenesis. Further exploration of the…

"To improve the understanding of LKB1 in physiology and oncology, this review highlights the role of LKB1 in tumorigenesis and addresses the therapeutic relevancy of LKB1 inhibitors." #LKB1 #STK11

2 0 0 0